MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $2.4M of Moderna, Inc.
Sold$2,363,556
$157.57Price
15,000Shares
What MRNA did after the filing
- The stock from Tue, May 28 open, $161.64
- −24.0%
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Jul 11 close.
Traded Wed, May 22. Filed Fri, May 24. Returns use the May 28 open and the Jul 11 close. Not investment advice.